Pharmacotherapies and personalized medicine for alcohol use disorder: a review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacotherapies and personalized medicine for alcohol use disorder: a review
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 21, Issue 15, Pages 1117-1138
Publisher
Future Medicine Ltd
Online
2020-08-18
DOI
10.2217/pgs-2020-0079
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic review and meta‐analysis of the moderating effect of rs1799971 in OPRM1 , the mu‐opioid receptor gene, on response to naltrexone treatment of alcohol use disorder
- (2020) Emily E. Hartwell et al. ADDICTION
- OPRM1 Moderates Daily Associations of Naltrexone Adherence With Alcohol Consumption: Preliminary Evidence From a Mobile Health Trial
- (2020) Christian S. Hendershot et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
- (2020) Emma M. O’Connell et al. Frontiers in Neuroscience
- A Meta‐analysis of the Efficacy of Gabapentin for Treating Alcohol Use Disorder
- (2019) Henry R. Kranzler et al. ADDICTION
- Lack of Association Between Serotonin Transporter Gene (SLC6A4) Promoter Methylation and Amygdala Response During Negative Emotion Processing in Individuals With Alcohol Dependence
- (2019) Christine Muench et al. ALCOHOL AND ALCOHOLISM
- Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis
- (2019) Lara A. Ray et al. ADDICTION BIOLOGY
- Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population
- (2019) James R. Walker et al. Journal of Studies on Alcohol and Drugs
- PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease
- (2019) Ji Soo Lee et al. Scientific Reports
- Baclofen for alcohol use disorder-a systematic meta-analysis
- (2018) T. Bschor et al. ACTA PSYCHIATRICA SCANDINAVICA
- Moderation of baclofen response by a GABAB receptor polymorphism: Results from the BacALD randomized controlled trial
- (2018) Kirsten C. Morley et al. ADDICTION
- Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis
- (2018) Abigail K. Rose et al. ADDICTION
- Association Analysis Between Genetic Variation in GATA Binding Protein 4 (GATA4) and Alcohol Use Disorder
- (2018) Kelsey L Mauro et al. ALCOHOL AND ALCOHOLISM
- Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial
- (2018) Lara A. Ray et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial
- (2018) Ryan T. Hurt et al. DRUG AND ALCOHOL DEPENDENCE
- Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)§
- (2018) Juliane Winkelmann et al. MOVEMENT DISORDERS
- Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking
- (2018) Stephanie S. O’Malley et al. JAMA Psychiatry
- Diagnosis and Pharmacotherapy of Alcohol Use Disorder
- (2018) Henry R. Kranzler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A randomized trial of low-dose gabapentin for post hospitalization relapse prevention in a Thai clinical sample of alcohol dependence
- (2018) Pattarin Chompookham et al. PSYCHIATRY RESEARCH
- A Review of the Potential Mechanisms of Action of Baclofen in Alcohol Use Disorder
- (2018) Renaud de Beaurepaire Frontiers in Psychiatry
- Gabapentin for the treatment of alcohol use disorder
- (2017) Barbara J. Mason et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effects of varenicline on alcohol self-administration and craving in drinkers with depressive symptoms
- (2017) Walter Roberts et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder
- (2017) F W Lohoff et al. MOLECULAR PSYCHIATRY
- Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status
- (2017) Joseph P Schacht et al. NEUROPSYCHOPHARMACOLOGY
- Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013
- (2017) Bridget F. Grant et al. JAMA Psychiatry
- Gabapentin misuse, abuse and diversion: a systematic review
- (2016) Rachel V. Smith et al. ADDICTION
- Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers
- (2016) Niamh Fitzgerald et al. ADDICTION
- Overview of the Genetics of Alcohol Use Disorder
- (2016) Elisabeth A. Tawa et al. ALCOHOL AND ALCOHOLISM
- Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential
- (2016) Michael Soyka EXPERT OPINION ON PHARMACOTHERAPY
- Different doses of gabapentin formulations for postherpetic neuralgia: A systematical review and meta-analysis of randomized controlled trials
- (2016) Juan Wang et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis
- (2015) Kim Donoghue et al. ADDICTION
- Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial
- (2015) Andrea de Bejczy et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- The Role of Gabapentin in the Management of Alcohol Withdrawal and Dependence
- (2015) Jonathan G. Leung et al. ANNALS OF PHARMACOTHERAPY
- Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts
- (2015) Tae-Hwi Schwantes-An et al. BEHAVIOR GENETICS
- Topiramate in Alcohol Use Disorders: Review and Update
- (2015) Riccardo Guglielmo et al. CNS DRUGS
- Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme
- (2015) Wim van den Brink et al. Expert Opinion On Drug Safety
- Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence
- (2015) Daniel E. Falk et al. Journal of Addiction Medicine
- Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses
- (2015) Anna D. Rubinsky et al. JOURNAL OF PSYCHIATRIC RESEARCH
- OPRM1 genotype and naltrexone response in depressed alcohol-dependent patients
- (2015) James A. Foulds et al. Pharmacogenetics and Genomics
- Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders
- (2015) Sarah G Helton et al. PHARMACOGENOMICS
- Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders
- (2015) Sarah G. Helton et al. PSYCHIATRY RESEARCH
- Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials
- (2015) Clément Palpacuer et al. PLOS MEDICINE
- Naltrexone vs Placebo for the Treatment of Alcohol Dependence
- (2015) David W. Oslin et al. JAMA Psychiatry
- Epidemiology ofDSM-5Alcohol Use Disorder
- (2015) Bridget F. Grant et al. JAMA Psychiatry
- Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: Exploratory findings
- (2014) George A. Kenna et al. ALCOHOL
- Ondansetron Reduces Naturalistic Drinking in Nontreatment-Seeking Alcohol-Dependent Individuals with the LL 5′-HTTLPR Genotype: A Laboratory Study
- (2014) George A. Kenna et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- A Meta-Analysis of Topiramate's Effects for Individuals with Alcohol Use Disorders
- (2014) Janet C. Blodgett et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Topiramate Treatment for Heavy Drinkers: Moderation by aGRIK1Polymorphism
- (2014) Henry R. Kranzler et al. AMERICAN JOURNAL OF PSYCHIATRY
- GABABmodulation of dopamine release in the nucleus accumbens core
- (2014) Kimberley A. Pitman et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Current pharmacological treatment approaches for alcohol dependence
- (2014) Christian A Müller et al. EXPERT OPINION ON PHARMACOTHERAPY
- GRIK1 Genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink
- (2014) Henry R. Kranzler et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings
- (2014) Daniel E. Jonas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study
- (2014) Wim van den Brink et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
- (2014) Marilyn D. Skinner et al. PLoS One
- The heritability of alcohol use disorders: a meta-analysis of twin and adoption studies
- (2014) B. Verhulst et al. PSYCHOLOGICAL MEDICINE
- Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate
- (2014) V M Karpyak et al. Translational Psychiatry
- Efficacy of Disulfiram for the Treatment of Alcohol Dependence Assessed with a Multicenter Randomized Controlled Trial
- (2013) Atsushi Yoshimura et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Determination of Genotype Combinations That Can Predict the Outcome of the Treatment of Alcohol Dependence Using the 5-HT3Antagonist Ondansetron
- (2013) Bankole A. Johnson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Gabapentin Versus Chlordiazepoxide for Outpatient Alcohol Detoxification Treatment
- (2013) Christopher J Stock et al. ANNALS OF PHARMACOTHERAPY
- Genetic Variation in the Atrial Natriuretic Peptide Transcription Factor GATA4 Modulates Amygdala Responsiveness in Alcohol Dependence
- (2013) Anne Jorde et al. BIOLOGICAL PSYCHIATRY
- Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: A 12-week, randomized, placebo-controlled trial
- (2013) Surinporn Likhitsathian et al. DRUG AND ALCOHOL DEPENDENCE
- A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence
- (2013) Kyle M. Kampman et al. DRUG AND ALCOHOL DEPENDENCE
- A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence
- (2013) Antoni Gual et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Pharmacological management of alcohol dependence: From mono-therapy to pharmacogenetics and beyond
- (2013) Fabio Caputo et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence
- (2013) Raye Z. Litten et al. Journal of Addiction Medicine
- Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
- (2012) Natalya C. Maisel et al. ADDICTION
- 5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity
- (2012) Henry R. Kranzler et al. ADDICTION BIOLOGY
- Association ofGATA4sequence variation with alcohol dependence
- (2012) Victor M. Karpyak et al. ADDICTION BIOLOGY
- Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis
- (2012) Antonio-Javier Chamorro et al. ADDICTION BIOLOGY
- Variation inOPRM1moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment
- (2012) Henry R. Kranzler et al. ADDICTION BIOLOGY
- Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study
- (2012) Karl Mann et al. ADDICTION BIOLOGY
- Naltrexone Modification of Drinking Effects in a Subacute Treatment and Bar-Lab Paradigm: Influence ofOPRM1and Dopamine Transporter (SLC6A3) Genes
- (2012) Raymond F. Anton et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene
- (2012) Karl Mann et al. BIOLOGICAL PSYCHIATRY
- The clinical pharmacology of acamprosate
- (2012) Nicola J. Kalk et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Functional Polymorphism of the Dopamine β-Hydroxylase Gene Is Associated With Increased Risk of Disulfiram-Induced Adverse Effects in Alcohol-Dependent Patients
- (2012) Jochen Mutschler et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- High-Dose Baclofen for Treatment-Resistant Alcohol Dependence
- (2012) Adam Pastor et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Genetic architectures of psychiatric disorders: the emerging picture and its implications
- (2012) Patrick F. Sullivan et al. NATURE REVIEWS GENETICS
- Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder
- (2012) F W Lohoff et al. PHARMACOGENOMICS JOURNAL
- Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol
- (2012) James R. Ashenhurst et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Preliminary Evidence for cue-induced Alcohol Craving Modulated by Serotonin Transporter Gene Polymorphism rs1042173
- (2012) Nassima Ait-Daoud et al. Frontiers in Psychiatry
- The Effect of Naltrexone on Alcohol’s Stimulant Properties and Self-Administration Behavior in Social Drinkers: Influence of Gender and Genotype
- (2011) Elaine Setiawan et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Pharmacogenetic Approach at the Serotonin Transporter Gene as a Method of Reducing the Severity of Alcohol Drinking
- (2011) Bankole A. Johnson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians
- (2011) Dingyan Chen et al. DRUG AND ALCOHOL DEPENDENCE
- Noradrenergic vs Serotonergic Antidepressant with or without Naltrexone for Veterans with PTSD and Comorbid Alcohol Dependence
- (2011) Ismene L Petrakis et al. NEUROPSYCHOPHARMACOLOGY
- OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence
- (2011) Janet K. Coller et al. Pharmacogenetics and Genomics
- Association analysis between the 5-HTTLPR polymorphism in the SLC6A4 gene and generalized anxiety disorder
- (2011) Sneha Narasimhan et al. PSYCHIATRIC GENETICS
- Genome-Wide Association Study of Alcohol Dependence Implicates a Region on Chromosome 11
- (2010) Howard J. Edenberg et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Rare genotype combination of the serotonin transporter gene associated with treatment response in severe personality disorder
- (2010) Nader Perroud et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- A Double-Blind, Placebo-Controlled Trial Combining Sertraline and Naltrexone for Treating Co-Occurring Depression and Alcohol Dependence
- (2010) Helen M. Pettinati et al. AMERICAN JOURNAL OF PSYCHIATRY
- Medications Acting on the Serotonergic System for the Treatment of Alcohol Dependent Patients
- (2010) George A. Kenna CURRENT PHARMACEUTICAL DESIGN
- Supervised Disulfiram as Adjunct to Psychotherapy in Alcoholism Treatment
- (2010) Henning Krampe et al. CURRENT PHARMACEUTICAL DESIGN
- Topiramate in the Treatment of Substance-Related Disorders
- (2010) Ann K. Shinn et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Double-Blind, Randomized Trial of Sertraline for Alcohol Dependence
- (2010) Henry R. Kranzler et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate
- (2010) F Kiefer et al. PHARMACOGENOMICS JOURNAL
- Topiramate for the Treatment of Alcohol Dependence: Comparison with Naltrexone
- (2010) Gerardo Flórez et al. EUROPEAN ADDICTION RESEARCH
- Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators
- (2009) Wendy Ooteman et al. ADDICTION BIOLOGY
- Role of the GABAB receptor in alcohol-seeking and drinking behavior
- (2009) Paola Maccioni et al. ALCOHOL
- An Open Trial of Gabapentin in Acute Alcohol Withdrawal Using an Oral Loading Protocol
- (2009) U. Bonnet et al. ALCOHOL AND ALCOHOLISM
- Association of Markers in the 3′ Region of the GluR5 Kainate Receptor Subunit Gene to Alcohol Dependence
- (2009) Henry R. Kranzler et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- A Double-Blind Trial of Gabapentin Versus Lorazepam in the Treatment of Alcohol Withdrawal
- (2009) Hugh Myrick et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Searching for Responders to Acamprosate and Naltrexone in Alcoholism Treatment: Rationale and Design of thePredict Study
- (2009) Karl Mann et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Genome-wide Association Study of Alcohol Dependence
- (2009) Jens Treutlein et al. ARCHIVES OF GENERAL PSYCHIATRY
- A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers.
- (2009) Lara A. Ray et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Targeted Naltrexone for Problem Drinkers
- (2009) Henry R. Kranzler et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effects of Topiramate on Urge to Drink and the Subjective Effects of Alcohol: A Preliminary Laboratory Study
- (2008) Robert Miranda Jr et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Effects of Opioid Receptor Gene Variation on Targeted Nalmefene Treatment in Heavy Drinkers
- (2008) Albert J. Arias et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- A Randomized Double-Blind Pilot Trial of Gabapentin Versus Placebo to Treat Alcohol Dependence and Comorbid Insomnia
- (2008) Kirk J. Brower et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- OPRM1Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach
- (2008) Gabor Oroszi et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Characterization of a Functional Polymorphism in the 3′ UTR of SLC6A4 and its Association With Drinking Intensity
- (2008) Chamindi Seneviratne et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence
- (2008) Raymond F. Anton et al. ARCHIVES OF GENERAL PSYCHIATRY
- Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians
- (2008) Cindy L Ehlers et al. BMC Medical Genetics
- Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty
- (2008) Tami L. Mark et al. DRUG AND ALCOHOL DEPENDENCE
- Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence
- (2008) Raymond F Anton PHARMACOGENOMICS
- A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients
- (2008) Sung-Gon Kim et al. PSYCHOPHARMACOLOGY
- Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?
- (2007) Bankole A. Johnson et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search